Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · IEX Real-Time Price · USD
3.83
-0.14 (-3.53%)
At close: Dec 29, 2023, 4:00 PM
3.90
+0.07 (1.83%)
After-hours: Dec 29, 2023, 7:13 PM EST
Acurx Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 1 stock analyst, the 12-month stock price forecast for ACXP stock stock is $14, which predicts an increase of 265.54%. On average, analysts rate ACXP stock stock as a strong buy.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for ACXP is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +265.54% | Dec 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +239.43% | Nov 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +239.43% | Sep 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +239.43% | Aug 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +265.54% | May 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.05
from -1.12
EPS Next Year
-0.85
from -1.05
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 289,800 | 3.7M | 53.1M |
| Avg | n/a | n/a | n/a | 140,760 | 1.8M | 32.6M |
| Low | n/a | n/a | n/a | n/a | n/a | 13.0M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | 2,537.1% | 2,847.4% |
| Avg | - | - | - | - | 1,180.9% | 1,705.5% |
| Low | - | - | - | - | - | 618.6% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.08 | -0.87 | -1.33 | -0.81 | -0.51 | 0.04 |
| Avg | -1.05 | -0.85 | -1.30 | -0.79 | -0.50 | 0.04 |
| Low | -1.01 | -0.81 | -1.24 | -0.75 | -0.48 | 0.04 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.